9 Atopic Dermatitis Clinical Trials in Fayetteville, NC (2026)

Q: How do I join a clinical trial in Fayetteville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you.

Recruiting Atopic Dermatitis Studies in Fayetteville

NCT07383441Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, pembrolizumab, cabozantinib, and lenvatin...

Fayetteville, NCPHASE3718 participantsSWOG Cancer Research Network

View Study Details

NCT07198074Recruiting

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

This phase III trial compares the effect of bevacizumab in combination with carboplatin, paclitaxel and pembrolizumab to the usual treatments of carboplatin and paclitaxel with or without pembrolizuma...

Fayetteville, NCPHASE3255 participantsNational Cancer Institute (NCI)

View Study Details

NCT06389136Recruiting

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants w...

Fayetteville, NCPHASE3200 participantsAbbVie

View Study Details

NCT07227298Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor ...

Fayetteville, NCPHASE1162 participantsPfizer

View Study Details

NCT06770582Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

This phase II trial compares the use of pembrolizumab and radiation therapy to chemotherapy with cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C and radiation therapy for the treatment of non-mu...

Fayetteville, NCPHASE2160 participantsNational Cancer Institute (NCI)

View Study Details

NCT07225569Recruiting

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different doses of SAR445399 in adult participants with modera...

Fayetteville, NCPHASE2144 participantsSanofi

View Study Details

NCT07061964Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

This phase II trial tests the effect of giving pembrolizumab in combination with radiation therapy after chemotherapy in preventing surgery to remove the bladder in patients with muscle invasive bladd...

Fayetteville, NCPHASE2111 participantsNational Cancer Institute (NCI)

View Study Details

NCT05952934Recruiting

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

This is a Phase II randomized, double-blind, placebo controlled, multi-site study of Candin. It is designed to show the efficacy and safety of a 7-dose regimen of Candin over a two-year period in term...

Fayetteville, NCPHASE2100 participantsUniversity of Arkansas

View Study Details

NCT06998940Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

This phase III trial compares the effect of adding panitumumab to standard chemotherapy (with nanoliposomal Irinotecan, leucovorin, and 5-fluorouracil \[5-FU\] or irinotecan, leucovorin, and 5-FU or n...

Fayetteville, NCPHASE394 participantsSWOG Cancer Research Network

View Study Details

About Atopic Dermatitis Clinical Trials in Fayetteville

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 9 atopic dermatitis clinical trials recruiting participants in Fayetteville, NC. These studies are seeking a combined 1,944 participants. Research is being sponsored by SWOG Cancer Research Network, National Cancer Institute (NCI), AbbVie and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Fayetteville — FAQ

Are there atopic dermatitis clinical trials in Fayetteville?

Yes, there are 9 atopic dermatitis clinical trials currently recruiting in Fayetteville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fayetteville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you about next steps.

Are clinical trials in Fayetteville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fayetteville studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 9 active trials in Fayetteville are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated September 5, 2026 from ClinicalTrials.gov